Alzheimer's Research

Jump to Section1. Introduction2. Methods  2.1. Participants  2.2. CSF measurements and classification  2.3. APOE genotyping  2.4. Analytic methods    2.4.1. Training and validation sets    2.4.2. LASSO regression modeling of baseline cognitive performance    2.4.3. Applying model weights to predict clinical diagnostic category    2.4.4. Using...

The Alzheimer's Drug Discovery Foundation (ADDF) honored actress, author, and advocate Marcia Gay Harden at its Hope on the Horizon Luncheon held at The Colony in Palm Beach...

1.Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353–356, https://doi.org/10.1126/science.1072994 (2002).2.Rowe, C. C. et al. Amyloid imaging results from the...

Risk-based factors for risk-based breast cancer screening including family history, race, age, prior breast biopsy, and breast density have not been evaluated in routine screening mammography practice. "Growing interest in...

Article in...

Posted on July 26, 2017 by Tom and Karen Brenner The Unbroken Circle ...

As part of its Diagnostics Accelerator research program, the Alzheimer's Drug Discovery Foundation (ADDF) announced today a new initiative that aims to fast-track the development of digital tools...

The aims, design and setting of the studyThe aim of this cross-sectional lab-based study was to quantify mtDNA in specific regions of post-mortem human brain and to determine if diabetes and AD, separately or...

Besides skin cancer, prostate cancer is the most common cancer in American men, according to the American Cancer Society. Recurrences of prostate cancer after a patient undergoes radical prostatectomy (RP),...

Fig. 2Macroscopic examples of AD-CBS and AD-AS; comparison of representative cases of AD-CBS (A, B, C) and AD-AS (D, E, F). The midsagittal view shows marked medial frontal atrophy, especially in paracentral lobule and perirolandic...